Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Analyst says Bristol-Myers may split off Mead Johnson shares, leading to gains for Mead stock
Yahoo/AP
Wed, 10/14/09 - 06:05 pm
Mead Johnson
Bristol-Myers Squibb
Analyst Sees New Life In Life Sciences Sector
Yahoo/Investors Business Daily
Mon, 10/12/09 - 11:21 am
Merck
Pfizer
Bristol-Myers Squibb
Analyst trims Bristol-Myers Squibb to 'Neutral'
Yahoo/AP
Sat, 10/10/09 - 12:02 pm
Bristol-Myers Squibb
EU approves AstraZeneca, Bristol diabetes drug
Marketwatch
Mon, 10/5/09 - 11:21 am
AstraZeneca
Bristol-Myers Squibb
Europe
diabetes
Onglyza
Warning: Potential Blockbuster Ahead
Motley Fool
Sat, 10/3/09 - 09:41 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study
WSJ Online
Fri, 10/2/09 - 10:40 am
stents
JNJ
Boston Scientific
Medtronic
Abbott Laboratories
Bristol-Myers Squibb
Sanofi
Eli Lilly
Daiichi Sankyo
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Yahoo/AP
Fri, 10/2/09 - 10:39 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Dapagliflozin
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Bloomberg
Thu, 10/1/09 - 07:31 am
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
Mylan says FDA approved its version of Bristol-Myers drug Sinemet for Parkinson's disease
Yahoo/AP
Wed, 09/30/09 - 10:49 am
Mylan
FDA
Parkinson's Disease
generics
Sinemet
Bristol-Myers Squibb
10 Health-Care Stocks To Consider Buying Now
iStockAnalyst
Mon, 09/28/09 - 11:22 am
Zimmer
JNJ
Covidien
Becton Dickinson
Abbott Laboratories
Merck
Medtronic
Novartis
Bristol-Myers Squibb
Genzyme
Bristol's High Hopes for Belatacept
Yahoo/Zacks
Sat, 09/26/09 - 10:55 am
Bristol-Myers Squibb
belatacept
Mixed Results for Bristol's Erbitux
Yahoo/Zacks.com
Fri, 09/25/09 - 11:53 am
Bristol-Myers Squibb
Erbitux
Amgen
Eli Lilly
Bristol-Myers still hungry for deals after Medarex
Reuters
Thu, 09/24/09 - 11:16 am
Bristol-Myers Squibb
Medarex
M&A
Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful
BNET Pharma
Mon, 09/21/09 - 05:23 pm
Effient
Onglyza
diabetes
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
The Next Biopharma M&A Targets
Barron's
Fri, 09/18/09 - 11:16 am
M&A
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Abbott Laboratories
JNJ
Novartis
Sanofi
Which Pharma Pipelines Rank Best?
Yahoo/Morningstar
Thu, 09/17/09 - 08:27 am
pipelines
AstraZeneca
Abbott Laboratories
Bristol-Myers Squibb
GSK
Novartis
Bristol-Myers sells Asia OTC business for $310M
Yahoo/AP
Wed, 09/16/09 - 09:10 am
Bristol-Myers Squibb
OTC
M&A
Taisho
Diabetes Medication May Get New Life as Cancer Treatment
WSJ Online
Mon, 09/14/09 - 08:13 pm
cancer
diabetes
metformin
Glugophase
Bristol-Myers Squibb
Biogen Maintains Facet Offer
Yahoo/Zacks.com
Thu, 09/10/09 - 08:52 am
Biogen Idec
Facet Biotech
M&A
Acorda Therapeutics
Bristol-Myers Squibb
FDA Reviewing Bristol Transplant Drug
Yahoo/AP
Fri, 09/4/09 - 09:53 am
FDA
transplant drugs
Bristol-Myers Squibb
belatacept
AstraZeneca
Eli Lilly
Pages
« first
‹ previous
…
107
108
109
110
111
112
113
114
115
…
next ›
last »